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Abstract
Background: There is scant knowledge of the involvement of developing country pharmacists in mental healthcare. 
The objectives of this study were: to examine the existing role of Ghanaian community and hospital pharmacists in the 
management of mental illness, and to determine the barriers that hinder pharmacists' involvement in mental 
healthcare in Ghana.
Method: A respondent self-completion questionnaire was randomly distributed to 120 superintendent community 
pharmacists out of an estimated 240 pharmacists in Kumasi, Ashanti Region of Ghana. A purposive sampling method 
was utilized in selecting two public psychiatric hospital pharmacists in Accra, the capital city of Ghana for a face-to-face 
interview. A semi-structured interview guide was employed.
Results: A 91.7% response rate was obtained for the community pharmacists' questionnaire survey. Approximately 
65% of community pharmacists were not involved in mental health provision. Of the 35% who were, 57% counseled 
psychiatric patients and 44% of these dispensed medicines for mental illness. Perceived barriers that hindered 
community pharmacists' involvement in the management of mental health included inadequate education in mental 
health (cited by 81% of respondents) and a low level of encounter with patients (72%). The psychiatric hospital 
pharmacists were mostly involved in the dispensing of medicines from the hospital pharmacy.
Conclusion: Both community and hospital pharmacists in Ghana were marginally involved in the provision of mental 
healthcare. The greatest barrier cited was inadequate knowledge in mental health.
Background
Mental and behavioral disorders are estimated to account
for 12% of the global burden of disease. The World Health
Organization (WHO) estimates that 25% of any popula-
tion will suffer from neuro-psychiatric conditions during
their lifetime [1]. In Ghana there is no current published
data on the prevalence of mental illness. However, 77,688
and 82,819 patients attended the three major mental
health institutions in 2001 and 2002 respectively [2]. The
commonest case diagnosed at these institutions was
schizophrenia.
On 9th October 2008 in Geneva, WHO launched its
mental health gap action program (mhGAP). This aims at
scaling up services for mental, neurological and sub-
stance use disorders, particularly in countries with low
and middle incomes. WHO believes that with proper
care, psychosocial assistance and medication, tens of mil-
lions could be treated for depression, schizophrenia, and
epilepsy, prevented from suicide and begin to lead nor-
mal lives even in resource-limited settings [3].
Health professionals have identified people with mental
illness as among their most challenging patients to man-
age [4]. Appropriate drug therapy helps treat mental
health problems, minimize relapse and reduce suicide [5].
Consequently, the primary goal of the pharmacist in
mental health provision should be the safety and well-
being of the patient, ensuring that patients who need
medicines receive them and adhere to treatment [6].
Indeed, WHO has acknowledged pharmacists as dynamic
members of the mental healthcare team who should
assist in improving psychotropic medication use [7].
In developed countries, pharmacists are involved in
both in-patient and out-patient psychiatric settings.
Pharmacists routinely participate as pharmacotherapy
experts and consultants, manage individual patient drug
regimens, obtain drug histories, lead patient education
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Page 2 of 8discussion groups, and coordinate the use of drug assis-
tance programs. A retrospective chart review has indi-
cated that duties performed by pharmacists in psychiatric
settings can improve physician prescribing practices and
enhance treatment outcomes [8]. These positive out-
comes, associated with savings in drug acquisition costs
could, theoretically, reduce the potential side effect bur-
den of the psychotropic agents administered and could
reduce the numbers of potentially inappropriate psycho-
tropic medications prescribed for mental illness [9-11].
Pharmacists in the United Kingdom play a role at every
stage of the patient's recovery, whether patients are being
cared for in an acute setting or in the community. Phar-
macists assess and advise on medication and are also
involved in lithium and depot injection clinics at the hos-
pital and in the community [12].
In a developing West African country like Ghana, little
is known about the contribution of pharmacists to mental
healthcare. This study seeks to provide current and rele-
vant information for the purposes of policy initiation,
planning and decision making, especially since the Ghana
mental health act is being reviewed. Healthcare profes-
sionals, notably practicing pharmacists, will also be
informed on the current as well as the possible role the
pharmacist could play in mental health delivery.
The objectives of the study were to examine the existing
role of the Ghanaian community and hospital pharmacist
in the management of mental illness and to determine the
barriers that hinder pharmacists' involvement in the
management of mental healthcare.
Method
Study sample
The study covered community pharmacists in the city of
Kumasi and the two psychiatric hospitals in Accra (Pan-
tang hospital and Accra psychiatric hospital). These areas
were selected because Pantang hospital and Accra psy-
chiatric hospital have the largest number of mental
patients in Ghana; and the city of Kumasi, a convenient
setting for the researchers, is the second largest city in
Ghana with approximately 240 community pharmacies.
In phase one of the study, a simple random sampling
technique was used to select 120 community pharmacies
out of the estimated 240 community pharmacies in
Kumasi. In phase two, purposive sampling was used to
select the pharmacist in charge of each of the two psychi-
atric hospitals for an interview. These pharmacists were
assumed capable of providing extensive information on
pharmacy practice at the hospital, having worked for at
least five years in that position. At the time of the study,
there were only two pharmacists employed in each of
these hospitals.
Development and validation of the survey instrument
The respondent self-completion questionnaire and the
semi-structured interview guide were developed primar-
ily by the researchers based on literature regarding phar-
maceutical care offered by community and hospital
pharmacists, with emphasis on mentally-challenged
patients. The questionnaire for community pharmacists
was aimed at determining pharmacists' role and knowl-
edge of, barriers to their increased involvement in, and
their views on regular workshops for Ghanaian commu-
nity pharmacists on the management of mental illness
(Appendix 1). The semi-structured interview guide,
designed for a face-to-face interview with the hospital
pharmacist, involved discussions on the current role of
the pharmacist on admission, ward rounds, discharge,
and views on the formation of medication education
groups among mentally-challenged patients (Appendix
2). Both of these instruments were then reviewed by a fel-
low researcher, a practicing community pharmacist and a
hospital pharmacist. They were also pre-tested on a sam-
ple of five community pharmacists and a hospital phar-
macist respectively, to check for precision, ease of
understanding and flow of content.
Ethical considerations
Permission for the study was sought from both the Phar-
maceutical Society of Ghana and the respective hospital
directors. Pharmacists were then informed about the
study and their consent sought before the questionnaire
was administered.
Data collection
In phase one of the study, the 120 community pharmacies
chosen for the study were visited from the 1st to 5th Febru-
ary 2009. The pharmacists in the selected community
pharmacies were then given two weeks to complete the
questionnaire and these were retrieved from the respon-
dents by EAB.
In phase two, appointments were booked for a face-to-
face interview with the pharmacists in charge of the hos-
pitals. The first appointment was on the 8th of January
2009 and the second appointment was on the 13th of Jan-
uary 2009. Both interviews were conducted by EAB.
Data analysis
Qualitative data was grouped into themes and SPSS ver-




Of the 120 questionnaires administered to the commu-
nity pharmacists, 110 were retrieved representing a
response rate of 91.7%.
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25% of the respondents were females and 75% were
males. The number of years of practice ranged from 1-5
years (50%), 6-10 years (41%) and over 10 years (9%).
Existing role of community pharmacists
65% of respondents did not play any role in the manage-
ment of mental health illness. However with regard to the
35% who did, the highest proportion (57%) was involved
with counseling associated with dispensing of medicines
to psychiatric patients (Table 1).
Community pharmacists' knowledge of psychotropic 
medicines
Seventy nine percent (79%) of respondents rated their
knowledge on psychotropic medicines as average, 2% as
good and 19% as poor. The main reason cited for a less
than good rating was inadequate education in the area of
mental health (Table 2).
Views of community pharmacists on regular workshops
All the respondents said regular workshops would help
improve their involvement in mental healthcare delivery.
Workshops could cover signs and symptoms of mental ill-
ness (65% of respondents), counseling (96%), psychotro-
pic medicines (79%) and current treatment regimens for
mental illness (86%).
Barriers hindering community pharmacists' involvement
Perceived barriers that hindered the community pharma-
cist's involvement in the management of mental health
included inadequate knowledge in the area (cited by 81%
of respondents), low level of encounter with mental
patients (72%), poor remuneration (56%), stigmatization
of patients and personnel in the field (59%) and inade-
quate funding of services (51%).
Role of hospital pharmacists' on patient admission
The two respondents said they played a role on patient
admission:
"On admission we check for the appropriateness of any
prescribed drugs, relating to the dose- and interaction
with other medication when the prescription is
brought to the pharmacy." (H1)
"On admission, we dispense any drugs needed and
help in stabilizing agitated patients by providing seda-
tives." (H2)
However, there was hardly any encounter between
pharmacists and patients, or pharmacists and carers dur-
ing admission; for medicine use review, counseling and
monitoring of therapy:
"... admission is mostly done at the records department
so we do not get to meet the carers. Also, most often,
the nurses come here for all the patients' medica-
tions."(H1)
"We do not do much drug history taking or review
here..." (H2)
Although the pharmacists did not see the carers or
patients on admission, they were of the opinion that it
was important for them to do so:
"...it could afford us the opportunity to counsel carers
on the medication of the patient and it could also help
us to know our patients better." (H1)
"It could help to foster good relations between the
pharmacist and the carers of the patients..."(H2)
Role of hospital pharmacists during ward rounds
Respondents reported that they seldom conducted ward
rounds and when they did, they did not go with other
members of the healthcare team. One respondent cited
his inadequate knowledge in psychiatry as a reason why
he did not go on ward rounds with other members of the
healthcare team:
"Well, on my part, I do not normally go for ward
rounds due to my limited knowledge in psychiatry. You
know in school we are not taught much of psychiatric
conditions and this would make contributions during
ward rounds difficult."(H1)
The other respondent explained that when she joined
the hospital there was no structured ward rounds with
other members of the healthcare team,
"... that is what is done here. I came to meet that here."
(H2)
Role of hospital pharmacists during discharge of patients
Both respondents reported that they did not play a mean-
ingful role during the discharge of patients.
Table 1: Roles of community pharmacists in the 
management of mental illness
Roles Frequency (Percentage)
Counseling 22 (57)
Dispensing of drugs 17 (44)
Provision of drug information 12(32)
Patient monitoring 8 (21)
Table 2: Reasons cited by community pharmacists for 
rating knowledge of psychotropic medicines as average or 
poor
Reason Frequency (Percentage)
Inadequate education in this area 80 (73)
Few prescriptions for mental health drugs 73 (66)
Inadequate material on mental health 
therapy
57 (45)
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come here for their drugs instead of their carers. So we
counsel the nurses on how the patients should take
their medication and hope they pass it on to the carers
or the patients themselves." (H1)
"Ideally, we should have followed up on patients after
discharge but this is not done here because there are
community mental health nurses who provide primary
care to discharged patients at the community level.
However, we sometimes help in determining the time a
discharged patient should come for review." (H2)
Hospital pharmacists' views on formation of medication 
education groups
It was apparent from the interviews that the respondents
had mixed feelings about the formation of such groups,
though they generally endorsed the view that if well-
formed, the groups could help improve drug compliance.
"Yes because if properly done, it could help to educate
patients on their medication, especially on issues of
drug compliance by letting them know why they take
their drugs. On the other hand, I would say no, because
most of these patients have communication problems.
Some do not know what they are talking about and
others even do not understand what is said to them.
Educating such a group will be very difficult if not
impossible." (H1)
"No, because most of the patients we have here are not
literate. Most of them even attach superstitious beliefs
to their illness. This will make communicating with
them very difficult and I wonder how it could help in




Of the 35% community pharmacists who reported play-
ing a role in the management of mental illness, only 44%
of these were involved with the dispensing of medicines
to psychiatric patients (Table 1). This is not surprising
because in Ghana most psychotropic medicines are dis-
pensed free of charge to patients at the government psy-
chiatric hospitals, thus patients visit the community
pharmacies to purchase medicines when the psychiatric
hospitals are out of stock or do not stock the psychotro-
pic medicines prescribed.
Community pharmacists' perceived knowledge and 
challenges
Ninety eight percent (98%) of respondents rated their
knowledge in psychotropic medicines as either average or
poor. This perceived inadequate education is likely to be
an important factor limiting their involvement in the
management of mental illness (the reason given by 81% of
the respondents for their non-involvement). This corrob-
orates with a study conducted in Belgium which showed
that lack of training in mental health issues was the most
important barrier hindering pharmacists' role in depres-
sion [13]. Although pharmacists are generally experts in
drug therapy, offering efficient pharmaceutical care to
mentally challenged patients can be quite daunting. Stud-
ies have indicated that the provision of information about
medications by community pharmacists may be limited
by poor communication with people with mental ill-
nesses [14]. Pharmacists have reported feeling more
uncomfortable counseling on the use of medications used
to treat mental illnesses than those used to treat cardio-
vascular conditions [15]. Hence specific knowledge and
skills are required so as to optimise treatments for men-
tally challenged patients.
All respondents were of the view that regular work-
shops would help improve their knowledge in mental
health care delivery. Pharmaceutical governing bodies,
such as the Pharmacy Council of Ghana, could help by
organizing these workshops for community pharmacists
and psychiatric hospital pharmacists to ensure that they
are equipped to perform their expected roles. Topics to
be covered could include; communication with mentally
challenged patients, pharmacotherapy and other duties
expected of the pharmacist as proposed by the commu-
nity pharmacists. However to adequately organise these
workshops, pharmacists and resource persons who are
experts in mental health would be needed. Currently
Ghana has nine consultant psychiatrists and no specialist
psychiatric pharmacist [Personal Communication, office
of the Chief Psychiatrist of Ghana]. Hence healthcare
personnel, especially psychiatric pharmacists in the
developed countries, could assist by volunteering their
services so as to upgrade psychiatric pharmacy in Ghana.
Furthermore universities offering pharmacy in Ghana
could offer postgraduate courses on psychiatric phar-
macy. In the United States there are approximately 25 to
30 one-year, post-Pharm. D residencies in psychiatric
pharmacy practice, with 17 receiving accreditation by the
American Society of Health-System Pharmacists (ASHP)
[16,17]. Each residency may offer a unique feature such as
an ambulatory care focus or teaching skills development;
however, the emphasis of residency training is on special-
ized clinical knowledge and skills development.
Seventy nine percent (79%) of the community pharma-
cists who responded to the questionnaire had never been
consulted by discharged mental patients or their carers
for advice on their medication. This could mean one of
two things: either mental illness was not a common con-
dition in the community or most people with the condi-
tion did not perceive the pharmacy as a place where they
could go for consultation on their medication.
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were discharged from the Ankaful, Pantang and Accra
psychiatric hospitals (Ankaful is the 3rd major psychiatric
hospital in Ghana) [2] and in a newspaper report on 8th of
August, 2008, the acting Chief Psychiatrist of the Accra
psychiatric hospital stated that about 440,000 Ghanaians
suffered a severe form of mental illness[18]. The second
reason, that most people with mental conditions do not
perceive the pharmacy as a place where they could go for
consultation on their mental health medication, is there-
fore more plausible and hence it is essential that the men-
tal health law that is being reviewed includes community
pharmacists as part of the community mental health
teams. This would also address the problem of low
encounter with patients cited by 72% as a perceived bar-
rier for hindering their involvement in mental health care
delivery. Duties of community psychiatric nurses include
awareness creation and mental health promotion, identi-
fication of cases and referral of cases to specialist hospi-
tals and management of some cases including counseling
[2]. These duties and more could be performed by com-
munity pharmacists working together with community
psychiatric nurses to upgrade pharmaceutical care of
mentally challenged patients. There is evidence that sug-
gests that pharmacists have a potential role as members
of community mental health teams. Pharmacists' partici-
pation in community psychiatry clinical team meetings
created an opportunity to present medication review
findings and recommendations. Pharmacists were also
perceived as a valuable source of unbiased and evidence-
based drug information for both mental health team staff
and their clients and caregivers [19]. There is also evi-
dence to the effect that counseling provided by commu-
nity pharmacists to discharged mental patients
significantly contribute to improved medication compli-
ance [4]. However adequate remuneration should be
given through the National Health Insurance Scheme
(NHIS) to community pharmacists to enhance their
interest in this area since poor remuneration was cited by
56% as a perceived barrier that hinders their involvement
in mental healthcare. Community pharmacies are also
more accessible to the general population, their opening
hours are usually convenient and they provide person-
alised services [20]. Therefore their involvement will also
aid in decentralization of mental healthcare, resulting in
greater accessibility.
Public awareness of the role played by pharmacists in
mental health delivery is essential, as this will increase the
level of pharmacists' encounter with mentally-challenged
patients. These services would then not seem strange to
clients as perceived by pharmacists in this study. Most
Ghanaians believe conditions like mental illness, convul-
sions and epilepsy to be spiritual and hence require spiri-
tual attention [2]. Thus most carers of patients with such
beliefs would rather take discharged patients showing
signs of relapse or discomfort due to side effects of psy-
chotropic medications to spiritual healers than seek
advice from a pharmacist.
To address perceived barriers of stigmatization of
patients and personnel in the field and inadequate fund-
ing as cited by 59% and 51% of community pharmacists
respectively, relevant policies should be formulated in
addition to other policies that avoid controversies over
roles within the healthcare team; and regulate traditional
healers, prayer camps and other unorthodox institutions.
The mental health law of Ghana is being revised to pro-
mote the care, and to protect the human rights, of people
with mental illness [21]. In 2006 the Government of
Ghana gave approval to the Ministry of Health (MOH)
Ghana to revise 19 outmoded health related laws in order
to improve health service delivery in the country. The
MOH is currently working on seven of these laws, includ-
ing the Mental Health Law which was last reviewed in
1972. Mental health service decentralization, infrastruc-
ture for management and rehabilitation of the mentally ill
in the community, condition of service in mental service,
mental health awareness and transportation for commu-
nity health services are being reviewed [2,21].
Hospital pharmacists
The study revealed that on admission, the psychiatric
hospital pharmacist checks for the appropriateness of any
drug prescribed for the patient, whiles dispensing the
medicines at the pharmacy. This does not differ widely
from what pharmacists in the general hospital setting do.
However, it was identified that on admission the pharma-
cist did not usually see the patient or the carer for a med-
ication review or drug history documentation, and all
information about prescribed medication was given to
the patient through the nurses. This is not the best
approach to optimize pharmaceutical care. Correct docu-
mentation of a patient's medication history is an impor-
tant part of the initial patient assessment after admission
to hospital [22]. Pharmacists, rather than physicians, have
been shown to obtain more accurate medication-related
information from patients [23]. Accurate medication his-
tory enables the healthcare team to have an idea of all
medications, including creams and any herbal prepara-
tions the patient had taken, any of which might even be a
contributing factor to the presenting illness.
Pharmacists in both hospitals did not usually conduct
ward rounds with other members of the healthcare team.
Lack of adequate team work between the pharmacist and
other members of the healthcare team was also identified
as a barrier to their involvement in ward rounds. Ward
rounds have been identified as the best opportunity for
pharmacists to contribute to patient care. It is where
decisions are made about the patient's care and it is there-
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are receiving the correct treatment [12].
The pharmacists in the two hospitals did not normally
see the patients when they were discharged. The nurses
usually obtained the patient's drugs from the pharmacy
and thus all information about the drugs was given to the
patient via the nurses. It is, however, important for the
pharmacists to be involved in planning the discharge care
and to interact with the patient and their carers. This
would help solve any issues with medications and foster a
good relationship between the pharmacist, patient and
carer [12].
Issues such as poor communication with patients and
the fact that most of the patients and their carers attached
superstitions to their condition could make the formation
of medication education groups difficult. However, the
formation of such groups could provide a forum for
patients to discuss their therapy and ask questions on
their medications. This could improve drug compliance
and thus reduce the frequency of relapses.
Policies should be in place detailing the role of the hos-
pital pharmacist in psychiatric hospitals in Ghana so as to
enhance pharmaceutical care of patients admitted at the
psychiatric hospitals since studies have shown that the
presence of the pharmacist on the ward improves accu-
racy of drug history documentation, reduce prescribing
cost and decrease the potential risk of patients in the hos-
pital [24].
Conclusion
The survey demonstrated that Ghanaian pharmacists in
community practice did not play any significant role in
the management of mental illness, were restricted by sev-
eral barriers in involving themselves in the management
of mental illness and would welcome regular workshops
on mental health. The psychiatric hospital pharmacists
were mostly involved in dispensing medicines from hos-
pital pharmacies. However they seldom played a role in
offering pharmaceutical care to psychiatric patients on
admission or during discharge. Barriers that hindered
these hospital pharmacists were similar to those per-
ceived by the community pharmacists and it is essential
that these barriers are addressed.
Appendix 1: Current role and knowledge of community 
pharmacists in management of mental illness
1. Do you play any role in mental health care delivery
Yes { } No { }
2. If yes, which of these duties do you perform (please
tick)
a) Dispensing of psychotropic medicines
b) Counseling of patients mentally challenged
c) Patient monitoring
d) Provision of drug information (esp. psychotro-
pic medicines)
e) Conducting medicines use reviews
3. Has any discharged mental patient or carer of a dis-
charged mental patient ever been to you for advice on
their medication? { } yes { } no
4. If yes, how would you rate their satisfaction after
talking to you?
{ } excellent { } poor { } good { } very poor { } aver-
age
5. How would you rate your current knowledge on
mental health drug therapy?
{ } excellent { } poor { } good { } very poor { } aver-
age
6. Please rate your interest in involving yourself in the
management of mental illness
{ } excellent { } poor { } good { } very poor { } aver-
age
7. Roughly, what percentage of the drugs in your
pharmacy are psychotropic agents? (0-
100%)...........................................................
8. If you scored below 20% above, please explain why




9. Please list some barriers to your increased involve-






10. Do you think regular workshops for community
pharmacists on mental health drug therapy will
improve how you handle cases of mental illness?
{ } yes { } no
11. If yes, please explain
.....................................................................................................
12. If no, please explain
.....................................................................................................







15. Number of years of practice
16. Sex Male/Female
Appendix 2: Semi structured guide for face to face 
interview with hospital pharmacist
Role on patient admission
1. Briefly, what role does the hospital psychiatric
pharmacist play on patient admission?
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by pharmacists in the general hospital and those
played by the pharmacist in the psychiatric hospital?
3. What does drug history review for newly admitted
mental patients entail?
4. Does the pharmacist in the psychiatric hospital
interview carers of patients on admission?
5. What do those interviews entail?
6. Do you think it is important for the hospital psychi-
atric pharmacist to interview carers of mental
patients on admission?
Role played on multidisciplinary team meetings and ward 
rounds
1. What role does the pharmacist in the psychiatric
hospital play during ward rounds?
2. In some hospitals, the pharmacist goes on ward
rounds alone first, before going with the other health-
care professionals. Is the same thing done here?
3. Do you think such a practice is good?
4. Briefly, what are some of your challenges during
ward rounds?
5. How do you propose such challenges could be over-
come?
Role played during discharge of patients
1. What role do you play in planning the discharge
care of patients?
2. What measures do you put in place to ensure com-
pliance of drug therapy of discharged mental
patients?
Views on formation of medication education groups
1. Do you think the formation of medication educa-
tion groups of mental patients will help in drug ther-
apy?Please explain.
2. What role could the psychiatric hospital pharma-
cist play in such groups?
3. What are some of the barriers to the formation of
such groups in your hospital?
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